Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083

  • George Somlo
  • , Paul H. Frankel
  • , Banu K. Arun
  • , Cynthia X. Ma
  • , Agustin A. Garcia
  • , Tessa Cigler
  • , Leah V. Cream
  • , Harold A. Harvey
  • , Joseph A. Sparano
  • , Rita Nanda
  • , Helen K. Chew
  • , Timothy J. Moynihan
  • , Linda T. Vahdat
  • , Matthew P. Goetz
  • , Jan H. Beumer
  • , Arti Hurria
  • , Joanne Mortimer
  • , Richard Piekarz
  • , Sharon Sand
  • , Josef Herzog
    • Lily R. Van Tongeren, Katherine V. Ferry-Galow, Alice P. Chen, Christopher Ruel, Edward M. Newman, David R. Gandara, Jeffrey N. Weitzel

Research output: Contribution to journal › Article › peer-review

93   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science